Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2/3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Ovarian Carcinosarcoma 1

Interventions

Cisplatin 18 Magnetic Resonance Spectroscopy 14 Specimen Handling 12 Gemcitabine 12 Carboplatin 12 pembrolizumab 11 Paclitaxel 9 Platinum 7 Pemetrexed 7 1,2-diaminocyclohexaneplatinum II citrate 7 atezolizumab 6 Radiotherapy, Intensity-Modulated 6 Radiotherapy 6 Radiation 6 Nivolumab 6 Doxorubicin 6 Surgical Procedures, Operative 5 Rituximab 5 Immunoglobulin G 5 Docetaxel 5 Disulfides 5 Biopsy 5 Bevacizumab 5 130-nm albumin-bound paclitaxel 5 Temozolomide 4 Drug Therapy 4 Dexamethasone 4 Cyclophosphamide 4 Cetuximab 4 venetoclax 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Antineoplastic Agents × 30 days × Clear all

NCT03651206 2026-06-01

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡